Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer
M Xing, AS Alzahrani, KA Carson, D Viola, R Elisei… - Jama, 2013 - jamanetwork.com
Importance BRAF V600E is a prominent oncogene in papillary thyroid cancer (PTC), but its
role in PTC-related patient mortality has not been established. Objective To investigate the …
role in PTC-related patient mortality has not been established. Objective To investigate the …
Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
M Xing, AS Alzahrani, KA Carson, YK Shong… - Journal of clinical …, 2015 - ascopubs.org
Purpose To investigate the prognostic value of BRAF V600E mutation for the recurrence of
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
papillary thyroid cancer (PTC). Patients and Methods This was a retrospective multicenter …
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta‐analysis
BACKGROUND: The effects of the BRAFV600E mutation on prognostic factors and poor
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
clinical outcomes in papillary thyroid cancer (PTC) have not been fully quantified. The …
Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience
C Gouveia, NT Can, A Bostrom… - … –head & neck …, 2013 - jamanetwork.com
Importance Papillary thyroid carcinoma (PTC) is the most common endocrine neoplasm. B-
type raf kinase (BRAF) V600E mutation has been proposed as a negative prognostic …
type raf kinase (BRAF) V600E mutation has been proposed as a negative prognostic …
[HTML][HTML] Associations between BRAFV600E and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis
C Liu, T Chen, Z Liu - World journal of surgical oncology, 2016 - Springer
Background The objective of this study is to perform a meta-analysis to evaluate the
associations between the BRAF V600E mutation status and aggressive clinicopathological …
associations between the BRAF V600E mutation status and aggressive clinicopathological …
BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
C Li, KC Lee, EB Schneider… - The Journal of Clinical …, 2012 - academic.oup.com
Background: There is conflicting literature regarding the association of the BRAF V600E
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
mutation and aggressive clinicopathological features of papillary thyroid cancer (PTC) …
Mortality risk stratification by combining BRAF V600E and TERT promoter mutations in papillary thyroid cancer: genetic duet of BRAF and TERT promoter mutations in …
Importance BRAF V600E andTERTpromoter mutations can coexist in papillary thyroid
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
cancer (PTC). This genetic duet was indicated to be involved in the aggressiveness of PTC …
BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
Abstract Background The BRAF V600E mutation is the most common genetic alteration
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
found in papillary thyroid cancer (PTC). Recent studies show that this mutation occurs more …
Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma
X Wei, X Wang, J Xiong, C Li, Y Liao… - BioMed Research …, 2022 - Wiley Online Library
Background. Over the past ten years, the incidence rate of papillary thyroid carcinoma (PTC)
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
worldwide has been increasing rapidly year by year, with the incidence rate increasing 6 …
Effects of Coexistent BRAFV600E and TERT Promoter Mutations on Poor Clinical Outcomes in Papillary Thyroid Cancer: A Meta-Analysis
S Moon, YS Song, YA Kim, JA Lim, SW Cho, JH Moon… - Thyroid, 2017 - liebertpub.com
Background: The presence of a telomerase reverse transcriptase (TERT) promoter mutation
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
has been suggested as a potential prognostic marker for thyroid cancer, and a synergistic …
相关搜索
- braf v600e mutation
- patients with papillary thyroid cancer
- recurrence of papillary thyroid cancer
- mortality risk thyroid cancer
- meta analysis thyroid cancer
- thyroid carcinoma lack of association
- thyroid carcinoma poor outcomes
- thyroid cancer higher rate
- thyroid cancer clinicopathological features
- thyroid carcinoma prognostic factors
- thyroid cancer genetic duet
- thyroid cancer tumor aggressiveness
- thyroid carcinoma university of california
- thyroid carcinoma san francisco
- thyroid carcinoma braf v600e
- thyroid cancer mortality in patients